MedPath

Study on pulmonary parenchymal destruction in bronchial asthma

Not Applicable
Recruiting
Conditions
Study on pulmonary parenchymal destruction in asthma
Registration Number
JPRN-UMIN000050641
Lead Sponsor
Ministry of Health, Labour and Welfare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1 Those who have a complication of respiratory disease other than the present illness of surgery, asthma, or COPD. 2 Those deemed inappropriate as subjects by the principal investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CT pulmonary parenchymal destruction index (Exponent D, low attenuation area percent), pathological index (alveolar space length (mean linear intercept), number of alveolar attachments, number of terminal bronchioles) in resected lung specimens
Secondary Outcome Measures
NameTimeMethod
Exploratory evaluation using mRNA microarray, Pulmonary elastic fiber-related factors including collagen I, collagen III, fibronectin, matrix metalloproteinase (MMP)-1,MMP-2, MMP-9, tissue inhibitor of metalloproteinase (TIMP)
© Copyright 2025. All Rights Reserved by MedPath